Skip to news
JQJO
Latest

Jury says Apple infringed Masimo blood oxygen patent | JQJO

Jury says Apple infringed Masimo blood oxygen patent

Jury says Apple infringed Masimo blood oxygen patent

Tap title to read story

0:00 / 0:26

A federal jury handed Masimo a win in its longstanding legal battle with Apple, finding the company infringed a Masimo patent covering blood-oxygen monitoring technology visible in Apple Watch Workout and Heart Rate features. Apple disputed the verdict, saying the single patent expired in 2022 and is specific to historic patient monitoring technology from decades ago. The company plans to appeal.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Cliff Booth Returns in New Sequel

Tap title to read story

0:00 / 0:45

JQJO

Find your next story

Search JQJO’s current coverage.